...
首页> 外文期刊>Journal of drug delivery science and technology >Mucoadhesive sustained-release tablets for vaginal delivery of Curcuma comosa extracts: Preparation and characterization
【24h】

Mucoadhesive sustained-release tablets for vaginal delivery of Curcuma comosa extracts: Preparation and characterization

机译:粘膜粘附缓释片剂,用于阴道递送Curcuma Comosa提取物:制备和表征

获取原文
获取原文并翻译 | 示例
           

摘要

The objectives of this study were to prepare and characterize the mucoadhesive vaginal tablets of Curcuma comosa (C. comosa) extract for local delivery of the active phytoestrogens in a sustained release manner. The oleoresin-like C. comosa extract was converted into apparently dry powder by adding it into the mixture of polymer, namely polycarbophil (PCP), hydroxypropylmethylcellulose (HPMC) or the blends of PCP: HPMC, and silica. The absence of interaction between C. comosa extract and excipients was confirmed using FTIR. C. comosa mucoadhesive powder was directly compressed into 24-mm capsule shape tablets. All prepared tablets had acceptable physical properties and uniformity of diarylheptanoids (DAs), namely (3R)-1,7-diphenyl-(4E, 6E)-4,6-heptadien-3-ol (DA1) and (3S)-1,7-diphenyl-(6E)-4,6-hepten-3-ol (DA2). Blending PCP with HPMC could improve swelling and mucoadhesive properties of the tablets (p < 0.05). In vitro release showed that DAs were released over a period of 72 h in a sustained manner. The almost complete DA release was found in the formulation prepared with HPMC, of which the mean dissolution time of DA1 and DA2 stood at 34.7 +/- 4.1 and 32.1 +/- 3.7 h, respectively. Stability study reveals that C. comosa tablets were stable in terms of tablet properties, DA content and release characteristics when stored in a refrigerator.
机译:本研究的目的是制备和表征姜黄粘膜(C.Comosa)提取物以持续释放方式局部递送活性植物雌激素的粘膜粘附性阴道片。通过将油树脂样C. COMOSA提取物转化为明显干燥的粉末,将其加入聚合物的混合物,即聚氨基酚(PCP),羟丙基甲基纤维素(HPMC)或PCP:HPMC和二氧化硅的混合物中。使用FTIR确认C. COMOSA提取物和赋形剂之间的相互作用。 C. Comosa Mucoad粘附粉末直接压制成24mm胶囊形状片剂。所有制备的片剂具有可接受的物理性质和二芳基甲酸酯(DAS)的均匀性,即(3R)-1,7-二苯基 - (4E,6E)-4,6-庚二烯-3-醇(DA1)和(3S)-1 ,7-二苯基 - (6e)-4,6-庚酮-3-醇(DA2)。将PCP与HPMC混合可以改善片剂的溶胀和粘膜粘附性(P <0.05)。体外释放表明,DAS以持续的方式在72小时内释放。在用HPMC制备的制剂中发现了几乎完全的DA释放,其中DA1和DA2的平均溶解时间分别为34.7 +/- 4.1和32.1 +/- 3.7小时。稳定性研究表明,当储存在冰箱中时,C. Comosa片剂在片剂性质,DA含量和释放特性方面是稳定的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号